Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake

被引:76
作者
Baker, M.
Parton, T.
机构
[1] Univ Sheffield, Sch Med, Acad Unit Clin Pharmacol, Pharmacokinet & Pharmacogenet Grp, Sheffield S10 2RX, S Yorkshire, England
[2] UCB, Global Explorat Dev, Slough, Berks, England
[3] UCB, Discovery DMPK, Slough, Berks, England
关键词
hepatic clearance; plasma protein binding; kinetics; modelling;
D O I
10.1080/00498250701658296
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatic clearance prediction, using scaled data obtained from hepatocytes and microsomes, often under-predicts the eventual observed clearance. This occurs commonly where the compound is highly bound and/or a sinusoidal transporter substrate. The authors' own laboratory observations and those reported in the literature indicate that consideration of transporter effects in vitro is not sufficient to provide a direct, quantitative estimate of hepatic clearance in vivo. The physiology of contributing processes has been reviewed and the processes were compiled into a kinetic model of compound disposition for a hepatocyte compartment. The model has variables describing the kinetic effects of plasma protein binding, sinusoidal uptake, passive permeability, and cellular disposition. Parameters were determined experimentally requiring, in some instances, assays less familiar or routine to Drug metabolism and pharmacokinetics (DMPK) laboratories. The model accurately fitted data for the hepatic disposition of a UCB-proprietary compound that did not undergo metabolism but was a substrate for protein binding and sinusoidal uptake. On addition of bovine serum albumin to the assay, the uptake kinetics approximated neither those for the free fraction nor the total concentration. However, the model accurately predicted the intermediate observed kinetics and illustrated the kinetic effects of plasma protein binding and the complex interplay between various competing and collaborating processes. Through the use of simulations the model illustrated the influence of different combinations and influences of hepatic kinetic processes. Possible causes behind the extraction of highly bound compounds were identified as (1) low compound permeability facilitating active uptake and (2) high permeability facilitating the role of intracellular metabolism. In almost all circumstances k(off) is not low enough (< 1 s(-1)) to limit the extraction of plasma protein bound compounds; however, k(on) still exerts an effect through competition with the uptake process. Crucially the model indicated the complex nature of the combined processes, whose broad range of effects on hepatic disposition could only be accurately determined with a kinetic model.
引用
收藏
页码:1110 / 1134
页数:25
相关论文
共 77 条
[1]  
Abu-Zahra TN, 2000, DRUG METAB DISPOS, V28, P807
[2]   BAYESIAN-ANALYSIS OF MINIMUM AIC PROCEDURE [J].
AKAIKE, H .
ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, 1978, 30 (01) :9-14
[3]   An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates [J].
Andersson, TB ;
Bredberg, E ;
Ericsson, H ;
Sjöberg, H .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (07) :715-721
[4]  
Andersson TB, 2001, DRUG METAB DISPOS, V29, P712
[5]  
Annaert PP, 2001, DRUG METAB DISPOS, V29, P1277
[6]   The binding of drugs to hepatocytes and its relationship to physicochemical properties [J].
Austin, RP ;
Barton, P ;
Mohmed, S ;
Riley, RJ .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :419-425
[7]   The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties [J].
Austin, RP ;
Barton, P ;
Cockroft, SL ;
Wenlock, MC ;
Riley, RJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) :1497-1503
[8]  
Baba Takahiko, 2002, Drug Metab Pharmacokinet, V17, P522, DOI 10.2133/dmpk.17.522
[9]   Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver [J].
Barter, Zoe E. ;
Bayliss, Martin K. ;
Beaune, Philip H. ;
Boobis, Alan R. ;
Carlile, David J. ;
Edwards, Robert J. ;
Houston, J. Brian ;
Lake, Brian G. ;
Lipscomb, John C. ;
Pelkonen, Olavi R. ;
Tucker, Geoffrey T. ;
Rostami-Hodjegan, Amin .
CURRENT DRUG METABOLISM, 2007, 8 (01) :33-45
[10]   Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics [J].
Berezhkovskiy, LM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (02) :364-374